Citigroup’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Buy |
25,589
+2,262
| +10% | +$1.08M | 0.01% | 1294 |
|
|
2025
Q4 | $13.6M | Buy |
23,327
+13,679
| +142% | +$6.99M | 0.01% | 1329 |
|
|
2025
Q3 | $4.43M | Sell |
9,648
-8,835
| -48% | -$3.3M | ﹤0.01% | 2059 |
|
|
2025
Q2 | $5.59M | Sell |
18,483
-28,736
| -61% | -$8.56M | ﹤0.01% | 1795 |
|
|
2025
Q1 | $15.6M | Sell |
47,219
-51,019
| -52% | -$16.8M | 0.01% | 1094 |
|
|
2024
Q4 | $30.3M | Buy |
98,238
+69,617
| +243% | +$19.6M | 0.03% | 737 |
|
|
2024
Q3 | $6.07M | Buy |
28,621
+12,559
| +78% | +$3.21M | 0.01% | 1688 |
|
|
2024
Q2 | $4.5M | Sell |
16,062
-16,728
| -51% | -$3.98M | ﹤0.01% | 1707 |
|
|
2024
Q1 | $8.76M | Buy |
32,790
+11,467
| +54% | +$2.7M | 0.01% | 1329 |
|
|
2023
Q4 | $4.93M | Sell |
21,323
-961
| -4% | -$168K | 0.01% | 1605 |
|
|
2023
Q3 | $3.25M | Buy |
22,284
+6,611
| +42% | +$1.24M | ﹤0.01% | 1668 |
|
|
2023
Q2 | $3.62M | Sell |
15,673
-7,740
| -33% | -$2.1M | ﹤0.01% | 1714 |
|
|
2023
Q1 | $5.67M | Sell |
23,413
-23,136
| -50% | -$6.3M | 0.01% | 1441 |
|
|
2022
Q4 | $13.5M | Sell |
46,549
-13,698
| -23% | -$1.34M | 0.02% | 977 |
|
|
2022
Q3 | $3.92M | Buy |
60,247
+27,931
| +86% | +$1.94M | 0.01% | 1691 |
|
|
2022
Q2 | $2.31M | Buy |
32,316
+24,268
| +302% | +$1.78M | ﹤0.01% | 2005 |
|
|
2022
Q1 | $790K | Sell |
8,048
-22,652
| -74% | -$1.91M | ﹤0.01% | 3169 |
|
|
2021
Q4 | $2.6M | Sell |
30,700
-7,093
| -19% | -$583K | ﹤0.01% | 2403 |
|
|
2021
Q3 | $3.02M | Sell |
37,793
-160,808
| -81% | -$13.9M | ﹤0.01% | 2192 |
|
|
2021
Q2 | $19.3M | Buy |
198,601
+163,308
| +463% | +$19.3M | 0.02% | 1018 |
|
|
2021
Q1 | $4.13M | Buy |
35,293
+32,988
| +1,431% | +$3.85M | ﹤0.01% | 1919 |
|
|
2020
Q4 | $256K | Buy |
2,305
+1,573
| +215% | +$192K | ﹤0.01% | 4798 |
|
|
2020
Q3 | $87K | Sell |
732
-9,292
| -93% | -$1.01M | ﹤0.01% | 5220 |
|
|
2020
Q2 | $1.14M | Buy |
10,024
+683
| +7% | +$67.2K | ﹤0.01% | 3421 |
|
|
2020
Q1 | $624K | Buy |
9,341
+5,721
| +158% | +$477K | ﹤0.01% | 3662 |
|
|
2019
Q4 | $330K | Sell |
3,620
-19,938
| -85% | -$1.93M | ﹤0.01% | 4774 |
|
|
2019
Q3 | $2.03M | Sell |
23,558
-19,807
| -46% | -$1.86M | ﹤0.01% | 2854 |
|
|
2019
Q2 | $4.55M | Buy |
43,365
+42,341
| +4,135% | +$4.54M | 0.01% | 2050 |
|
|
2019
Q1 | $129K | Sell |
1,024
-48,969
| -98% | -$6.09M | ﹤0.01% | 5509 |
|
|
2018
Q4 | $5.63M | Buy |
49,993
+39,851
| +393% | +$6.17M | 0.01% | 1712 |
|
|
2018
Q3 | $2.17M | Sell |
10,142
-53
| -0.5% | -$13.3K | ﹤0.01% | 2656 |
|
|
2018
Q2 | $2.85M | Sell |
10,195
-6,243
| -38% | -$1.1M | 0.01% | 2371 |
|
|
2018
Q1 | $1.92M | Buy |
16,438
+14,802
| +905% | +$1.83M | ﹤0.01% | 2630 |
|
|
2017
Q4 | $150K | Buy |
+1,636
| New | +$93.4K | ﹤0.01% | 5293 |
|
|
2017
Q3 | – | Sell |
-11,351
| Closed | -$185K | – | 7360 |
|
|
2017
Q2 | $185K | Buy |
+11,351
| New | +$177K | ﹤0.01% | 4867 |
|
|
2016
Q3 | – | Sell |
-99
| Closed | -$1K | – | 7128 |
|
|
2016
Q2 | $1K | Sell |
99
-2,230
| -96% | -$26.8K | ﹤0.01% | 6985 |
|
|
2016
Q1 | $20K | Buy |
2,329
+1,339
| +135% | +$11.2K | ﹤0.01% | 6543 |
|
|
2015
Q4 | $12K | Buy |
990
+570
| +136% | +$15.6K | ﹤0.01% | 6739 |
|
|
2015
Q3 | $25K | Sell |
420
-296
| -41% | -$21.4K | ﹤0.01% | 5878 |
|
|
2015
Q2 | $55K | Buy |
716
+64
| +10% | +$5.37K | ﹤0.01% | 5459 |
|
|
2015
Q1 | $44K | Sell |
652
-440
| -40% | -$37.7K | ﹤0.01% | 5607 |
|
|
2014
Q4 | $101K | Buy |
1,092
+928
| +566% | +$96K | ﹤0.01% | 5219 |
|
|
2014
Q3 | $17K | Buy |
164
+65
| +66% | +$9.04K | ﹤0.01% | 5988 |
|
|
2014
Q2 | $14K | Sell |
99
-499
| -83% | -$72.9K | ﹤0.01% | 6012 |
|
|
2014
Q1 | $91K | Sell |
598
-352
| -37% | -$69.3K | ﹤0.01% | 5074 |
|
|
2013
Q4 | $175K | Buy |
950
+465
| +96% | +$85.1K | ﹤0.01% | 4768 |
|
|
2013
Q3 | $107K | Buy |
485
+374
| +337% | +$79.6K | ﹤0.01% | 4664 |
|
|
2013
Q2 | $19K | Buy |
+111
| New | +$28.9K | ﹤0.01% | 5846 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
